United States securities and exchange commission logo

                          October 3, 2022

       Stanley Jacot, Jr.
       President and Chief Executive Officer
       Arcadia Biosciences, Inc.
       202 Cousteau Place, Suite
       Davis, CA 95618

                                                        Re: Arcadia
Biosciences, Inc.
Statement on Form S-1
                                                            Filed September 27,
                                                            File No. 333-267637

       Dear Stanley Jacot, Jr.:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Cindy
Polynice at 202-551-8707 with any questions.


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Mike DeAngelis